“Molecular signature” in blood of liver cancer diagnosed patients as a criterion for optimal therapy modalities

Detalles Bibliográficos
Autores principales: Golubnitschaja, Olga, Cebioglu, Melanie, Yeghiazaryan, Kristina, Pieper, Claus C, Schild, Hans H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Meeting Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125931/
http://dx.doi.org/10.1186/1878-5085-5-S1-A38
_version_ 1782329832733933568
author Golubnitschaja, Olga
Cebioglu, Melanie
Yeghiazaryan, Kristina
Pieper, Claus C
Schild, Hans H
author_facet Golubnitschaja, Olga
Cebioglu, Melanie
Yeghiazaryan, Kristina
Pieper, Claus C
Schild, Hans H
author_sort Golubnitschaja, Olga
collection PubMed
description
format Online
Article
Text
id pubmed-4125931
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41259312014-08-12 “Molecular signature” in blood of liver cancer diagnosed patients as a criterion for optimal therapy modalities Golubnitschaja, Olga Cebioglu, Melanie Yeghiazaryan, Kristina Pieper, Claus C Schild, Hans H EPMA J Meeting Abstract BioMed Central 2014-02-11 /pmc/articles/PMC4125931/ http://dx.doi.org/10.1186/1878-5085-5-S1-A38 Text en Copyright © 2014 Golubnitschaja et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Meeting Abstract
Golubnitschaja, Olga
Cebioglu, Melanie
Yeghiazaryan, Kristina
Pieper, Claus C
Schild, Hans H
“Molecular signature” in blood of liver cancer diagnosed patients as a criterion for optimal therapy modalities
title “Molecular signature” in blood of liver cancer diagnosed patients as a criterion for optimal therapy modalities
title_full “Molecular signature” in blood of liver cancer diagnosed patients as a criterion for optimal therapy modalities
title_fullStr “Molecular signature” in blood of liver cancer diagnosed patients as a criterion for optimal therapy modalities
title_full_unstemmed “Molecular signature” in blood of liver cancer diagnosed patients as a criterion for optimal therapy modalities
title_short “Molecular signature” in blood of liver cancer diagnosed patients as a criterion for optimal therapy modalities
title_sort “molecular signature” in blood of liver cancer diagnosed patients as a criterion for optimal therapy modalities
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125931/
http://dx.doi.org/10.1186/1878-5085-5-S1-A38
work_keys_str_mv AT golubnitschajaolga molecularsignatureinbloodoflivercancerdiagnosedpatientsasacriterionforoptimaltherapymodalities
AT cebioglumelanie molecularsignatureinbloodoflivercancerdiagnosedpatientsasacriterionforoptimaltherapymodalities
AT yeghiazaryankristina molecularsignatureinbloodoflivercancerdiagnosedpatientsasacriterionforoptimaltherapymodalities
AT pieperclausc molecularsignatureinbloodoflivercancerdiagnosedpatientsasacriterionforoptimaltherapymodalities
AT schildhansh molecularsignatureinbloodoflivercancerdiagnosedpatientsasacriterionforoptimaltherapymodalities

Ejemplares similares